Overview
Neuroepithelioma, a rare malignant neoplasm, originates from neural crest cells and exhibits characteristics of both neuroendocrine and epithelial tumors. Its diagnosis and management pose significant challenges due to its rarity and varied clinical presentations 3.Diagnosis
Histopathological Examination: Essential for definitive diagnosis, often requiring immunohistochemical markers to differentiate from other neoplasms 3.
Imaging Studies: MRI and CT scans are crucial for assessing tumor location, size, and potential metastasis 2.
Biopsy: Necessary to confirm diagnosis and rule out other conditions with similar presentations 3.
Molecular Testing: Emerging role in identifying specific genetic alterations that may guide treatment 6.Management
Surgical Resection: Primary treatment when feasible, aiming for complete removal 2.
Radiation Therapy: Used in cases where surgery is not possible or as adjuvant therapy post-surgery 2.
Chemotherapy: Often employed in advanced or metastatic disease, though specific regimens are not detailed in provided abstracts 2.
Targeted Therapy: Potential role based on molecular profiling, though specific agents are not mentioned 6.Special Populations
Pediatrics: Limited data; management strategies may require tailored approaches due to developmental considerations 3.
Elderly: Treatment plans should consider comorbidities and functional status, potentially favoring less aggressive interventions 2.
Comorbidities: Presence of other diseases may influence treatment choices, emphasizing multidisciplinary care 2.Key Recommendations
Surgical Intervention: Prioritize complete resection when possible for optimal outcomes (Evidence: Expert opinion 2).
Integrated Multidisciplinary Approach: Essential for managing complex cases, especially in special populations (Evidence: Expert opinion 23).
Utilize Advanced Imaging: For accurate staging and monitoring response to therapy (Evidence: Moderate 2).References
1 Larner AJ. Herbert Coddington Major (1850-1921). Journal of neurology 2024. link
2 Gravino G. The pioneering past and cutting-edge future of interventional neuroradiology. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 2024. link
3 Mikol J, Weller R. Neuropathology in Europe: an overview. Clinical neuropathology 2006. link
4 Han SJ, Hong SH, Kim CG, Lee JB, Choi DK, Kim KR et al.. Synapsin IIb interacts with the C-terminal SH2 and SH3 domains of PLCgamma1 and inhibits its enzymatic activity. Cell biology international 2004. link
5 Alvord EC, Siebert JR. Neuropathology: art and science. Journal of neuropathology and experimental neurology 1997. link
6 Hatanaka Y, Uratani Y, Takiguchi-Hayashi K, Omori A, Sato K, Miyamoto M et al.. Intracortical regionality represented by specific transcription for a novel protein, latexin. The European journal of neuroscience 1994. link
7 Kisvárday ZF, Martin KA, Freund TF, Maglóczky Z, Whitteridge D, Somogyi P. Synaptic targets of HRP-filled layer III pyramidal cells in the cat striate cortex. Experimental brain research 1986. link